Impact of Insurance Coverage Changes on Life Sciences

This document is a report that outlines the anticipated effects of tightening insurance coverage on the life sciences sector. It discusses how policy-driven changes in Medicaid eligibility and the expiration of Health Insurance Marketplace subsidies are projected to increase the number of uninsured individuals by approximately 10 million by 2034. The report details the expected consequences of these changes, including a rise in the underinsured population and a potential decrease in demand for healthcare services, which may adversely affect annual sales revenue for life sciences firms. Additionally, it highlights the financial strain on healthcare providers, who may face increased reliance on emergency care and higher levels of bad debt. The report also presents strategic considerations for life sciences companies, indicating that revenue impacts will vary by market and may range from 8% to 14% in high-risk areas. It emphasizes the need for firms to evaluate their portfolios and align strategies with these market shifts.